SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-137410
Filing Date
2021-11-12
Accepted
2021-11-12 06:51:08
Documents
60
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lptx-20210930x10q.htm   iXBRL 10-Q 1640321
2 EX-10.1 lptx-20210930xex10d1.htm EX-10.1 26778
3 EX-31.1 lptx-20210930xex31d1.htm EX-31.1 12671
4 EX-32.1 lptx-20210930xex32d1.htm EX-32.1 9065
  Complete submission text file 0001104659-21-137410.txt   6376876

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA lptx-20210930.xsd EX-101.SCH 44180
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lptx-20210930_cal.xml EX-101.CAL 44876
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lptx-20210930_def.xml EX-101.DEF 169240
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20210930_lab.xml EX-101.LAB 434692
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20210930_pre.xml EX-101.PRE 314207
10 EXTRACTED XBRL INSTANCE DOCUMENT lptx-20210930x10q_htm.xml XML 1072159
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37990 | Film No.: 211399413
SIC: 2834 Pharmaceutical Preparations